Literature DB >> 20450464

Perinatal profile of very low birthweight infants under a universal newborn hearing screening programme in a developing country: a case-control study.

Bolajoko O Olusanya1.   

Abstract

OBJECTIVE: To determine the perinatal profile and developmental risks of very low birth weight (VLBW) infants (<or=1500 g) under a universal hearing screening programme in a resource-poor country.
METHODS: A case-control study of VLBW survivors matched by date of birth and sex with normal birth weight (>or=2500 g) infants delivered in an inner-city maternity hospital in Lagos, Nigeria. Hearing status was determined by two-stage screening with transient evoked otoacoustic emissions (TEOAE) followed by automated auditory brainstem response (AABR). Maternal and infant factors associated with VLBW were determined using unconditional and conditional multivariable logistic regression analyses.
RESULTS: All 45 VLBW singletons (mean weight 1.3 +/- 0.1 kg) during the study period were matched with 225 controls (mean weight 3.4 +/- 0.5 kg). VLBW was associated with maternal occupation, lack of antenatal care, low 5-minute Apgar score and hyperbilirubinemia based on unmatched and matched analyses. Additionally, VLBW infants were significantly associated with failed or incomplete hearing screening outcomes. Four (10.5%) of the 38 infants tested with AABR failed, but none returned for diagnostic evaluation and one child had previously passed TEOAE.
CONCLUSIONS: VLBW infants in resource-poor settings are associated with the risk of sensorineural hearing loss and other perinatal outcomes that may potentially compromise their optimal development in early childhood.

Entities:  

Mesh:

Year:  2010        PMID: 20450464     DOI: 10.3109/17518420903468472

Source DB:  PubMed          Journal:  Dev Neurorehabil        ISSN: 1751-8423            Impact factor:   2.308


  1 in total

1.  Socioeconomic disadvantage, fetal environment and child development: linked Scottish administrative records based study.

Authors:  Christopher James Playford; Chris Dibben; Lee Williamson
Journal:  Int J Equity Health       Date:  2017-11-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.